<unk>  (INN) is an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria. Its combination (co-formulation) with Lumefantrine has first been marketed by Novartis under the brand names Riamet and Coartem. Today, this combination therapy is available as generic from several manufacturers.
Artemether
Debrisoquine
Delamanid
Quinine
Flumequine
Piperaquine
Mefloquine
Tafenoquine